Clones of cells lacking active p53 have a survival advantage in a hypoxic environment (Graeber et al, 1996), consistently, the hypoxic environment present in the tumour mass in vivo is supposed to select clones carrying defective p53 (Graeber et al, 1996; Semenza, 2003). The gene discussed is TP53; the disease is neoplasm.